The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.
November 26th 2024
The investigators of this study noted an association between obesity and conditions such as rosacea, psoriasis, and lichen simplex chronicus.
November 22nd 2024
November 19th 2024
Scientists Identify Mechanism of Action of Potential Psoriasis Therapy
March 12th 2015Researchers in Germany have figured out the process by which interleukin 4 (IL-4) inhibits inflammation, pointing the way toward a possible treatment for psoriasis, psoriatic arthritis, and other autoimmune diseases.
New Test to Aid Melanoma Diagnosis: Ready for Clinical Use?
myPath Melanoma, a new 23-gene signature test fromMyriad Genetics, could potentially differentiate between malignant melanoma and benign skin moles in nearly 15% of cases where histopathologic analysis is not considered straightforward.
Researchers Identify Potential Protein Triggers of Psoriasis
February 20th 2015Researchers have reportedly identified several proteins that are highly prevalent in human psoriasis and may play an important role in the development and progression of the disease and its co-morbidities and complications, including psoriatic arthritis.
Leiomyomas and Vaginal Misoprostol: Reducing Hemorrhage
February 19th 2015Approximately 20% of women develop leiomyomas during their childbearing years. When these uterine fibroids cause excessive bleeding, pelvic pain, cramping, or painful intercourse, surgery is indicated. Hysterectomy is an appropriate choice for women who are done with childbearing, but for women with childbearing plans for the future, myomectomy is an option. However, hemorrhage is a common complication during myomectomy.
Adding Topical Corticosteroids to a Regimen of Etanercept in Patients with Plaque Psoriasis
February 13th 2015The addition of a topical corticosteroid to once-weekly etanercept produces similar outcomes among patients with moderate to severe plaque psoriasis as a regimen of twice weekly etanercept at the same dose.
Plaque Psoriasis: Switching Biologics Effective, Study Finds
Researchers have recently shown that switching from one biological agent to another could potentially prove effective for patients with plaque psoriasis when the initial treatment agent elicits insufficient response.
Innovative App for Skin Cancer Diagnosis Launched on World Cancer Day 2015
A new, free mobile application that could potentially detect skin cancer, was made available on World Cancer Day, February 4, 2015, for physicians and dermatologists in the United States, United Kingdom, and Australia.
Human Pluripotent Stem Cells: The Future of Hair Regeneration?
Hair loss, whether partial or close to baldness, is a condition that is frequently associated with feelings of poor self-confidence (even depression in severe cases) across all demographics of affected patients.
FDA Approves New Psoriasis Drug
The US Food and Drug Administration (FDA) approved secukinumab (Cosentyx/Novartis) for adults with moderate to severe plaque psoriasis. The European Commission approved the same drug on Jan. 19. Its active ingredient is an antibody that binds to interleukin-17A and interferes with inflammation. The binding prevents that protein from triggering the inflammatory response that results in psoriasis patches.